Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review
Expert Opinion on Therapeutic Patents · 2024
DOI: 10.1080/13543776.2024.2367006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Opinion on Therapeutic Patents, 2024. Verfasst von Massimiliano Gasparrini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agriculture, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy. Hauptthemen laut MEDLINE: Nicotinamide Phosphoribosyltransferase, Patents as Topic, Neoplasms, NAD. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: This manuscript was funded by University research funding 2022 of Polytechnic University of Marche to MG.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Agriculture, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.
- NEUROFARBA Department, Pharmaceutical Chemistry Section, University of Florence, Sesto Fiorentino, Florence, Italy.
Förderung
- This manuscript was funded by University research funding 2022 of Polytechnic University of Marche to MG
Zitieren
APA
Gasparrini, M., Giovannuzzi, S., Nocentini, A., Raffaelli, N., & Supuran, C. T. (2024). Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review. Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2024.2367006
Vancouver
Gasparrini M, Giovannuzzi S, Nocentini A, Raffaelli N, Supuran CT. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review. Expert Opinion on Therapeutic Patents. 2024. doi:10.1080/13543776.2024.2367006
BibTeX
@article{Gasparrini2024,
author = {Gasparrini, Massimiliano and Giovannuzzi, Simone and Nocentini, Alessio and Raffaelli, Nadia and Supuran, Claudiu T},
title = {Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review},
journal = {Expert Opinion on Therapeutic Patents},
year = {2024},
doi = {10.1080/13543776.2024.2367006}
}
EUVIMED